Steinert 39 S disease

Clinical trials for Steinert 39 S disease explained in plain language.

Never miss a new study

Get alerted when new Steinert 39 S disease trials appear

Sign up with your email to follow new studies for Steinert 39 S disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for DM1: Long-Term trial of AOC 1001 underway

Disease control By invitation only

This phase 3 study is testing the long-term safety and effectiveness of an experimental drug called AOC 1001 (del-desiran) for people with myotonic dystrophy type 1 (DM1), a genetic muscle disorder. The trial enrolls 230 adults who have completed a prior AOC 1001 study and will r…

Matched conditions: STEINERT 39 S DISEASE

Phase 3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

Last updated Aug 21, 2026 00:00 UTC

Steinert 39 S disease

Get alerted when new Steinert 39 S disease trials appear

New hope for DM1: Long-Term trial of AOC 1001 underway